WO2025224605 - SEQUENTIAL ADMINISTRATION OF ANTI-MELANOMA VACCINE AND ANTI-PD-1 MONOCLONAL ANTIBODIES
National phase entry is expected:
Publication Number
WO/2025/224605
Publication Date
30.10.2025
International Application No.
PCT/IB2025/054161
International Filing Date
21.04.2025
Title **
[English]
SEQUENTIAL ADMINISTRATION OF ANTI-MELANOMA VACCINE AND ANTI-PD-1 MONOCLONAL ANTIBODIES
[French]
ADMINISTRATION SÉQUENTIELLE D'UN VACCIN ANTI-MÉLANOME ET D'ANTICORPS MONOCLONAUX ANTI-PD-1
Applicants **
CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET)
FUNDACIÓN SALES
ARIS, Mariana
Inventors
MORDOH, José
BARRIO, María Marcela
SCHWAB, Erika
BRAVO, Alicia Inés
Priority Data
63/637,463
23.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2427 | |
| EPO | Filing, Examination, Granting | 13291 | |
| Japan | Filing, Examination, Granting | 2462 | |
| South Korea | Filing, Examination, Granting | 2595 | |
| USA | Filing, Examination, Granting | 5540 |
Total:
26,315
Contact Us
Abstract[English]
Methods for enhancing an anti-tumor immune response to treatment in a subject who has cutaneous melanoma (CM). In particular, the subject is treated with anti-PD-1 monoclonal antibodies (MAbs) following treatment with a vaccine generating an immune response against antigens of CM cells.[French]
L'invention concerne des méthodes pour améliorer une réponse immunitaire antitumorale à un traitement chez un sujet atteint d'un mélanome cutané (MC). En particulier, le sujet est traité avec des anticorps monoclonaux (MAb) anti-PD-1 après traitement avec un vaccin générant une réponse immunitaire contre des antigènes de cellules de MC.